![Jan Niclas Wester](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Niclas Wester
Chief Executive Officer at Scintomics GmbH
Network origin in Jan Niclas Wester first degree
Entity | Entity type | Industry | |
---|---|---|---|
Scintomics GmbH
![]() Scintomics GmbH Pharmaceuticals: MajorHealth Technology Scintomics GmbH is a privately held German company that specializes in innovative targeted theranostics and corresponding radiopharmaceutical technologies for personalized cancer care. The company is based in Graefelfing, Germany and was founded in 2006. The company's pipeline includes functional diagnostics and radiotherapeutics such as pentixafor and pentixather for theranostics of lymphoproliferative diseases and theridat for adrenocortical cancer. The company's groundbreaking radiohybrid technology and its first lead compound rhpsma-7 allow the true bridging of functional imaging and therapy. Scintomics considers the license agreement, the future collaboration with Blue Earth Diagnostics, and the further adaption of the radiohybrid technology to other targeted cancer theranostics as an important milestone towards its strong positioning as a radiopharmaceutical development specialist. The CEOs are Jan Niclas Wester and Andrea Maugg.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jan Niclas Wester via their personal network
Company | Sector | Related people | Main position |
---|
Statistics
International
Sectoral
Operational
Chief Executive Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Andrea Maugg | 1 |
- Stock Market
- Insiders
- Jan Niclas Wester
- Company connections